New nasal spray mumps vaccines enter human testing
⭐️ VACCINE ⭐️
Ongoing
This early-stage trial is testing two new mumps vaccines given as a nasal spray, called CVM150 and CVM26, in up to 60 healthy adults aged 18-29. The main goal is to check if they are safe and to see how well they trigger an immune response. Unlike traditional shots, these vaccine…
Phase: PHASE1 • Sponsor: CyanVac LLC • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:03 UTC